Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. [2][3][4][5]
In a separate announcement, Cencora's unit AmerisourceBergen Specialty Group (ABSG), said the information stolen was in connection with a prescription supply program offered by its now-defunct ...
Stefano Pessina (2022-present) Website. www.ornellabarra.com. Ornella Barra (born 20 December 1953) is an Italian-born Monegasque businesswoman. [1] A qualified pharmacist, she is chief operating officer, international of Walgreens Boots Alliance. [2][3] She is married to the Italian billionaire Stefano Pessina. [4][5]
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, [2] which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens bought ...
This list comprises the world's largest companies by consolidated revenue, according to the Fortune Global 500 2024 rankings and other sources. [2] American retail corporation Walmart has been the world's largest company by revenue since 2014. [1] The list is limited to the largest 50 companies, all of which have annual revenues exceeding US ...
Cencora, which makes a major chunk of its revenue from its U.S.-focused business, said revenue from the unit was boosted by increased demand for newer diabetes drugs belonging to the GLP-1 class ...